[Correlation between serum growth differentiation factor 11 level and severity of coronary artery disease in patients

B D Xu1, K Chen1, Y H Liu1

  • 1Department of Cardiologyg, the 904th Hospital of Joint Logistic Support Force of People's Liberation Army of China, Wuxi 214000, China.

PubMed

Insights

Lower serum growth differentiation factor 11 (GDF11) levels are linked to ST-segment elevation myocardial infarction (STEMI). A nomogram model integrating GDF11 and traditional risk factors improves STEMI prediction.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Context:

  • ST-segment elevation myocardial infarction (STEMI) is a critical cardiovascular event.
  • Identifying novel biomarkers for STEMI risk stratification is crucial.
  • Growth Differentiation Factor 11 (GDF11) is a protein with potential roles in cardiovascular health.

Purpose:

  • To investigate the association between serum GDF11 levels and coronary artery lesions in STEMI patients.
  • To evaluate the predictive capability of a nomogram model incorporating GDF11 and traditional risk factors for STEMI occurrence.

Summary:

  • Serum GDF11 levels were significantly lower in STEMI patients compared to controls.
  • GDF11, along with smoking, diabetes, C-reactive protein, homocysteine, lipoprotein (a), and apolipoprotein A1/B, were identified as independent risk factors for STEMI.
  • Serum GDF11 showed a negative correlation with the severity of coronary artery lesions (SYNTAX and Gensini scores).

Impact:

  • The study identifies serum GDF11 as a novel independent risk factor for STEMI.
  • A combined nomogram model using GDF11 and traditional factors demonstrates superior predictive accuracy for STEMI compared to models using only traditional factors or GDF11 alone.
  • This enhanced predictive model can aid in early risk assessment and management of STEMI patients.